Prospect of cetuximab in the treatment of colorectal cancer
10.3760/cma.j.issn.1673-9752.2013.07.022
- VernacularTitle:EGFR靶向药物西妥昔单抗在结直肠癌治疗中的应用进展
- Author:
Hongtao LI
;
Hongbin LIU
;
Qingchuan ZHAO
;
Xiaopeng HAN
;
Wankun ZHU
;
Lin SU
- Publication Type:Journal Article
- Keywords:
Colorectal neoplasms;
Targeted therapy
- From:
Chinese Journal of Digestive Surgery
2013;(7):556-560
- CountryChina
- Language:Chinese
-
Abstract:
Colorectal cancer is one of the most common malignant tumors.With the improvement of living condition and peoples' life-span,the incidence rate of colorectal cancer has been ascending year by year.In developed countries and developed district of China,colorectal cancer has become the second common malignant tumor.More than one million people were diagnosed as with colorectal cancer,and 500,000 of them died yearly.Colorectal cancer is one of the most common reasons of the death of cancer patients.With the development of molecular targeted agents research,the therapeutic effects for colorectal cancer patients have been improved,and the current status and prospect of targeted therapy for colorectal cancer patients were introduced in this review.